JOHANNESSEN JAN
SEC Form 4 insider trading activity
JOHANNESSEN JAN has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 14, 2026.
On the most recent filing, JOHANNESSEN JAN is listed as Director at Twist Bioscience Corp. Inside the rolling window, JOHANNESSEN JAN reported no open-market purchases and 2 open-market sales totaling $779K in TWST. The largest disclosed transaction in the window is a sale of 12,000 TWST shares on May 12, 2026, worth $673K.
Companies traded
Other insiders at TWST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$779K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has JOHANNESSEN JAN made?
JOHANNESSEN JAN has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does JOHANNESSEN JAN trade?
JOHANNESSEN JAN has filed SEC Form 4 disclosures for 1 company, including TWST.
When was JOHANNESSEN JAN's most recent SEC Form 4 filing?
JOHANNESSEN JAN's most recent SEC Form 4 filing on Tracefour is dated May 14, 2026.
What is JOHANNESSEN JAN's total buy and sell value in the current window?
Inside the rolling retention window, JOHANNESSEN JAN bought $0 and sold $779K based on SEC Form 4 filings.
What was JOHANNESSEN JAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,000 TWST shares on 2026-05-12, worth $673K, per SEC Form 4 filings.